Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Terminated Phase 1 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0030487 (Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01045928Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin LymphomaTreatment